IGF1 and neoplasm: Together with these studies, our results support the previous findings that SRC‐3 activating many important components of IGF/AKT pathway at both transcription and phosphorylation levels should lead to tumor progression by ensuring the efficient downstream signaling to enhance growth and invasion 16, 18.